← Back to Search

Radiation Shielding

Rampart IC, M1128 for Nuclear Radiation Emergency (RAMPART Trial)

N/A
Waitlist Available
Led By Varinder P Singh, M.D.
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Summary

This trial tests the Rampart IC, M1128, a portable device that shields medical staff from radiation without heavy aprons. It targets lab staff who often have pain from wearing lead aprons. The device works by blocking radiation with a movable shield, easing physical strain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in radiation attenuation

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Rampart M1128 IC, OnlyExperimental Treatment1 Intervention
Consented providers will perform catherization procedures utilizing only the Rampart system. Radiation will be measured by dosimeters worn by the providers.
Group II: Lead Apron + Rampart IC, M1128Experimental Treatment1 Intervention
Consented providers will perform catherization procedures utilizing both lead apron and Rampart system. Radiation will be measured by dosimeters worn by the providers.
Group III: Lead Apron OnlyActive Control1 Intervention
This is the control group. Consented providers will perform catherization procedures utilizing only the lead apron and ancillary shields (lead skirt, vest, thyroid collar (all at least 0.5mm Pb) with use of under table lead per lab operating policy and mobile suspended lead-acrylic shield and lead glasses). Radiation will be measured by dosimeters worn by the providers.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rampart IC, M1128 and Lead Apron
2022
N/A
~70
Rampart IC, M1128
2022
N/A
~70

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
473 Previous Clinical Trials
472,209 Total Patients Enrolled
Varinder P Singh, M.D.Principal InvestigatorSenior Vice President, Cardiology
~18 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top